Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
Moderna narrowed its loss in the recent quarter as revenue climbed, boosted by deliveries made under a government contract in the U.K.
Find insight on Sanofi, Haleon, Cochlear and more in the latest Market Talks covering the health care sector.
Chevron saw profits surge in the second quarter on soaring prices for refined products.
Exxon (XOM) delivered earnings and revenue surprises of -4.35% and +21.10%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Eaton (ETN) delivered earnings and revenue surprises of +2.27% and +6.57%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Cameco (CCJ) delivered earnings and revenue surprises of -50.00% and +10.04%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Find insight on Ferrari, Stellantis, Air France-KLM and more in the latest Market Talks covering the auto and transport sector.
Investing.com -- Colgate-Palmolive Company (NYSE:CL) reported second-quarter earnings before the open on Friday, topping earnings expectations.
In crypto news today (July 30), Bitcoin climbed -0.5% overnight, dropping below $64,000 following yesterday’s FOMC meeting, in which a rate hike wasn’t announced but SEC Chair Paul Atkins hinted at hikes to come, causing a slight sell-off across crypto. However, crypto held up well in comparison to the US ...
Ares Management (ARES) delivered earnings and revenue surprises of 0.00% and -4.16%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
July 31 (Reuters) - U.S. equity funds drew inflows in the week to July 29, snapping a two-week streak of outflows, as investors added exposure to mega-cap technology funds during a recent selloff on
Strong cloud results lifted Amazon and chipmakers, while Apple's service revenue shortfall sent its stock lower ahead of Friday's open
July 31 (Reuters) - Walmart-owned Flipkart said on Friday it has partnered with Netflix to offer members of its loyalty programme a monthly mobile subscription after four qualifying orders, as it
Microsoft stock surged 16% on Thursday after the company forecast Azure cloud growth well above analyst expectations
Colgate-Palmolive recorded higher sales in the second quarter, despite a choppy consumer environment.
Moderna posted a narrower per-share loss and higher revenue in its latest quarter, but shares were tumbling anyway. Moderna posted a loss of $1.97 a share, narrower than the loss of $2.01 Wall Street had anticipated, and slimmer than the per-share loss of $2.13 reported last year. The drugmaker reiterated its full-year guidance of 10% revenue growth, evenly split between U.S. and international sales.
Chevron (CVX) delivered earnings and revenue surprises of +4.48% and +21.78%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
July 31 (Reuters) - Enbridge beat estimates for second-quarter adjusted profit on Friday, helped by higher volumes of liquids transported on its Mainline system.
Several brokerages, including Barclays, Goldman Sachs, BTIG, and Clear Street, lowered their price targets on COIN stock following the earnings report.
Adjusted second-quarter earnings of $3.52 a share came in 2 cents below analyst forecasts, with scheduled maintenance limiting fuel-making profits
The department store’s iconic sign in Herald Square was taken down. Meanwhile, the apparel retailer went public on the low end of its price range.
Roblox stock is handed two Sell ratings after second-quarter earnings disappoint and guidance shows a worrying trend.
Investing.com -- ExxonMobil shares slid around 2% in premarket trading Friday after the U.S. energy major reported earnings for the second quarter that missed average analyst forecasts.
Investing.com -- Cameco Corp. (TSX: CCO; NYSE: CCJ) reported second quarter results that beat revenue expectations but fell short on earnings, with shares rising 3.3% premarket following the announcement.
Private-fund manager Ares Management reported record fundraising of $36.4 billion in the second quarter, rebounding from a slowdown earlier in the year. The amount of money raised climbed about 24% from the first quarter of this year and 39% from the second quarter of 2025. Fundraising from Ares business development companies—a type of private-credit fund commonly sold to individual investors—dipped, but that was offset by a surge in sales of funds to institutional clients, like pensions and sovereign wealth funds.
Biotechnology company Moderna (NASDAQ:MRNA) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 2.1% year on year to $145 million. Its GAAP loss of $1.97 per share was 4.2% above analysts’ consensus estimates.
Magna (MGA) delivered earnings and revenue surprises of +21.57% and +2.19%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
The Wall Street Journal reports Tesla is considering selling its China business to facilitate a future merger with SpaceX.
Sanofi wants to broaden the company’s productive partnership with Regeneron, its CEOs said. Elsewhere, Bristol Myers delayed two anticipated study readouts and a Shionogi-backed startup went public.
Can we count your visit with Google Analytics? No ads, no profiles. Details
